Non-hypocalcaemia n = 144 | Hypocalcaemia n = 20 | P value | |
---|---|---|---|
Demographical data | |||
Male, n (%) | 12 (8) | 4 (20) | 0.100 |
Age, years | 71 [63 to 77] | 74 [66 to 77] | 0.488 |
Body weight, kg | 47 [41 to 55] | 45 [41 to 53] | 0.385 |
Body mass index, kg/m2 | 21 [19 to 24] | 21 [18 to 22] | 0.185 |
Co-existing diseases | |||
Rheumatoid arthritis, n (%) | 24 (17) | 2 (10) | 0.444 |
Systemic lupus erythematosus, n (%) | 11 (8) | 1 (5) | 0.671 |
Vasculitis, n (%) | 5 (3) | 0 (0) | 0.397 |
Interstitial pneumonia, n (%) | 8 (6) | 2 (10) | 0.436 |
Inflammatory bowel disease, n (%) | 12 (8) | 1 (5) | 0.605 |
Laboratory data | |||
Serum Albumin, g/dL | 4.1 [3.8 to 4.3] | 4.0 [3.6 to 4.1] | 0.032 |
Serum creatinine, mg/dL | 0.66 [0.56 to 0.78] | 0.74 [0.56 to 1.06] | 0.175 |
eGFRa, mL/min/1.73m2 | 69.3 [58.0 to 85.5] | 60.2 [43.8 to 93.3] | 0.298 |
eGFR category, n (%) | 0.088 | ||
≥ 90 mL/min/1.73m2 | 25 (17) | 5 (25) | |
60 to 89 mL/min/1.73m2 | 79 (55) | 5 (25) | |
30 to 59 mL/min/1.73m2 | 35 (24) | 9 (45) | |
15 to 29 mL/min/1.73m2 | 3 (2) | 0 (0) | |
< 15 mL/min/1.73m2 | 2 (1) | 1 (5) | |
Serum calciumb, mg/dL | 9.5 [9.3 to 9.8] | 9.1 [9.0 to 9.4] | < 0.001 |
Co-administered medication | |||
Calcium and vitamin D supplementsc, n (%) | 81 (56) | 7 (35) | 0.074 |
Vitamin D preparation, n (%) | 46 (32) | 7 (35) | 0.784 |
Calcium preparation, n (%) | 0 (0) | 2 (10) | 0.596 |
Proton pump inhibitors, n (%) | 61 (42) | 13 (65) | 0.057 |
Loop diuretics, n (%) | 8 (6) | 3 (15) | 0.114 |
Thiazide diuretics, n (%) | 0 (0) | 3 (15) | 0.515 |